Remove 2021 Remove Compounding Remove Pharmaceutical Companies
article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Utilising content metrics to improve digital engagement

pharmaphorum

The 2021 Veeva Pulse Content Metrics Report provides information on how current digital trends impact the commercial content landscape and how Veeva utilises these trends to improve brand engagement. Digital content can then be approved quicker without jeopardising content compliant delivery.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

OSD contract manufacturing market valued at $54.7 billion by 2030

European Pharmaceutical Review

billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Tablets were noted to be the most common form of OSD in 2021 because of their convenience and simplicity in production, transportation and delivery to the end user. This is especially beneficial as a way of decreasing potential side effects.

Dosage 98
article thumbnail

The osteoarthritis market is expected to increase to $3.8bn in 2031

Pharmaceutical Technology

billion in the 7MM (seven major markets) in 2021, and is expected to increase to $3.8 billion in 2031, at a compound annual growth rate (CAGR) of 4.4%. The OA space has long been dominated by large pharmaceutical companies such as Bayer, Pfizer, and Eli Lilly. The osteoarthritis (OA) market was valued at $2.5

article thumbnail

Innovation in small molecules: Leading companies in quinoline derivatives as anticancer agents

Pharmaceutical Technology

According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry. The structure of quinoline is represented by the fusion of benzene ring with pyridine at two neighbouring carbon atoms.

article thumbnail

Evaluating NMR relaxometry for antibody identification

European Pharmaceutical Review

NMR relaxation methods distinguish between components (phases or compounds) that have different molecular mobilities For monoclonal antibodies, identification methodologies can employ chromatography, spectroscopy, isoelectric focusing, capillary electrophoresis and peptide mapping techniques. IPQ International Pharmaceutical Quality.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. 4, Issue 3, July 2021, pp. Recycling of medical plastics.